{"prompt": "['2014-0546', 'August 7, 2017', 'Page 47 of 49', 'Appendix 7: List of Clinical Laboratory Tests', 'Serum Chemistry Panel :', 'Complete Blood Count with Differential:', 'Serum albumin', 'White blood cells (WBC)', 'Total protein', 'Neutrophils (absolute count)', 'Total bilirubin', 'Lymphocytes (absolute count)', 'Direct bilirubin (if total bilirubin > ULN only)', 'Monocytes (absolute count)', 'Aspartate transaminase (AST)', 'Basophils (absolute count)', 'Alanine transaminase (ALT)', 'Eosinophils (absolute count)', 'Lactate dehydrogenase (LDH)', 'Red blood cells (RBC)', 'Alkaline phosphatase', 'Hematocrit', 'Bicarbonate', 'Hemoglobin (Hgb)', 'Sodium', 'Mean corpuscular volume (MCV)', 'Potassium', 'Mean corpuscular hemoglobin (MCH)', 'Chloride', 'Mean corpuscular hemoglobin concentration (MCHC)', 'Serum creatinine', 'Platelets (PLT)', 'BUN', 'Mean platelet volume', 'Glucose', 'Calcium', 'Phosphorus', 'Uric acid', 'Hyponatremia Panel (if Grade 3 Hyponatremia):', 'Urinalysis:', 'Serum osmolality', 'pH', 'Urine osmolality', 'Specific gravity', 'Serum albumin', 'Protein', 'BUN', 'Glucose', 'Serum creatinine', 'WBC', 'Serum sodium', 'Blood/occult blood', 'Urinary sodium', 'Ketone', 'Crystals (microscopic analysis)', 'Other Serum Laboratory Tests:', 'Pregnancy test (if childbearing potential):', 'Blood or urine pregnancy tests', 'Serum endogenous erythropoietin', 'Serum ferritin']['2014-0546', 'August 7, 2017', 'Page 48 of 49', 'Appendix 8: List of Potential Substrates of CYP 2C8 and 2C9', 'Reference: Flockhart 2007', 'Substrates of CYP 2C8 and 2C9 include, but are not limited to, drugs below:', '2C8 Substrates', '2C9 Substrates', 'amodiaquine', 'NSAIDs:', 'cerivastatin', 'diclofenac', 'paclitaxel', 'ibuprofen', 'repaglinide', 'lornoxicam', 'sorafenib', 'meloxicam', 'torsemide', 'S-naproxen->Nor', 'piroxicam', 'suprofen', 'Oral Hypoglycemic Agents:', 'tolbutamide', 'glipizide', 'Angiotensin II Blockers:', 'losartan', 'irbesartan', 'Sulfonylureas:', 'glyburide', 'glibenclamide', 'glipizide', 'glimepiride', 'tolbutamide', 'Others:', 'amitriptyline', 'celecoxib', 'fluoxetine', 'fluvastatin', 'glyburide', 'nateglinide', 'phenytoin-4-OH2', 'rosiglitazone', 'tamoxifen', 'torsemide', 'S-warfarin', 'Sulfamethoxazole']['2014-0546', 'August 7, 2017', 'Page 49 of 49', 'Appendix 9: List of Potential Inhibitors of P-gp', 'Reference: FDA Guidance', 'Examples of In Vivo Inhibitors of Human Transporter P-gP (MDR1)', 'Amiodarone', 'Azithromycin', 'Captopril', 'Carvedilol', 'Clarithromycin', 'Conivaptan', 'Cyclosporine', 'Diltiazem', 'Dronedarone', 'Erythromycin', 'Felodipine', 'Itraconazole', 'Ketoconazole', 'Lopinavir & Ritonavir', 'Quercetin', 'Quinidine', 'Ranolazine', 'Ticagrelor', 'Verapamil']\n\n###\n\n", "completion": "END"}